These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6274602)

  • 21. Cell-free synthesis of encephalomyocarditis virus.
    Svitkin YV; Sonenberg N
    J Virol; 2003 Jun; 77(11):6551-5. PubMed ID: 12743313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A highly efficient and robust in vitro translation system for expression of picornavirus and hepatitis C virus RNA genomes.
    Svitkin YV; Sonenberg N
    Methods Enzymol; 2007; 429():53-82. PubMed ID: 17913619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nature of a virus-specific protein detected in the composition of a ribonucleoprotein containing cellular messenger RNA during viral infection].
    Kalinina NO; Kuroedov AA; Skarlat IV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (9):28-34. PubMed ID: 6252976
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-stranded RNA as an inhibitor of protein synthesis and as a substrate for a nuclease in extracts of Krebs II ascites cells.
    Robertson HD; Mathews MB
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):225-9. PubMed ID: 4346034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Initiation of RNA synthesis by the encephalomyocarditis virus in a cell-free system and the possible participation of VPg protein in this process].
    Vartapetian AB; Kunin EV; Chumakov KM; Bogdanov AA; Agol VI
    Dokl Akad Nauk SSSR; 1982; 267(4):963-5. PubMed ID: 6295728
    [No Abstract]   [Full Text] [Related]  

  • 26. Polyribosome patterns in EMC-virus infected Krebs-2 cells and cell extracts.
    Kaverin NV; Kukhanova MK
    Experientia; 1967 Dec; 23(12):1010-1. PubMed ID: 4294862
    [No Abstract]   [Full Text] [Related]  

  • 27. A poly(A) tail-responsive in vitro system for cap- or IRES-driven translation from HeLa cells.
    Thoma C; Ostareck-Lederer A; Hentze MW
    Methods Mol Biol; 2004; 257():171-80. PubMed ID: 14770005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factor facilitating complete translation of the encephalomyocarditis virus genome].
    Svitkin IuV; Agol VI
    Dokl Akad Nauk SSSR; 1981; 258(4):1013-5. PubMed ID: 6265184
    [No Abstract]   [Full Text] [Related]  

  • 29. A protein synthesizing system from interferon-treated cells that discriminates between cellular and viral messenger RNAs.
    Samuel CE; Joklik WK
    Virology; 1974 Apr; 58(2):476-91. PubMed ID: 4820887
    [No Abstract]   [Full Text] [Related]  

  • 30. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA.
    Kaminski A; Hunt SL; Patton JG; Jackson RJ
    RNA; 1995 Nov; 1(9):924-38. PubMed ID: 8548657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficiency of translation of viral and cellular mRNA's in extracts from cells infected with encephalomyocarditis virus.
    Svitkin YV; Ugarova TY; Ginevskaya VA; Kalinina NO; Scarlat IV; Agol VI
    Intervirology; 1974; 4(4):214-20. PubMed ID: 4376807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of poly(9-vinyladenine) and poly(1-vinyluracil) on messenger ribonucleic acid template activity.
    Reynolds FH; Pitha PM; Chuang R; Cheng TC; Kazazian HH; Grunberger D
    Mol Pharmacol; 1975 Nov; 11(6):708-15. PubMed ID: 1207669
    [No Abstract]   [Full Text] [Related]  

  • 33. 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.
    Silverman RH; Cayley PJ; Wreschner DH; Knight M; Gilbert CS; Brown RE; Kerr IM
    Tex Rep Biol Med; 1981-1982; 41():479-86. PubMed ID: 6189212
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of a number of antitumor preparations on RNA- and protein-synthesizing processes and viral interferon induction in Krebs 2 ascites carcinoma cells].
    Shloma DV; Krispin TI; Balandin IG
    Vopr Virusol; 1982; 27(6):735-8. PubMed ID: 6186093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of initiation rates of encephalomyocarditis virus and host protein synthesis in infected cells.
    Jen G; Birge CH; Thach RE
    J Virol; 1978 Sep; 27(3):640-7. PubMed ID: 212586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encephalomyocarditis virus RNA synthesis in vitro is protein-primed.
    Vartapetian AB; Koonin EV; Agol VI; Bogdanov AA
    EMBO J; 1984 Nov; 3(11):2593-8. PubMed ID: 6096134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors controlling amino acid incorporation by ribosomes from krebs II mouse ascites-tumour cells.
    Kerr IM; Cohen N; Work TS
    Biochem J; 1966 Mar; 98(3):826-35. PubMed ID: 4287844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chicken or the egg: microRNA-mediated regulation of mRNA translation or mRNA stability.
    Omer AD; Janas MM; Novina CD
    Mol Cell; 2009 Sep; 35(6):739-40. PubMed ID: 19782024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-molecular-weight protein component required for natural messenger translation in ascites tumor cells.
    Strycharz WA; Ranki M; Dahl HH
    Eur J Biochem; 1974 Oct; 48(1):303-10. PubMed ID: 4375033
    [No Abstract]   [Full Text] [Related]  

  • 40. Cis-acting elements of the encephalomyocarditis virus internal ribosomal entry site.
    Witherell GW; Schultz-Witherell CS; Wimmer E
    Virology; 1995 Dec; 214(2):660-3. PubMed ID: 8553572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.